Cargando…

Neoadjuvant Chemotherapy for Breast Cancer: Evolution of Clinical Practice in a French Cancer Center Over 16 Years and Pathologic Response Rates According to Tumor Subtypes and Clinical Tumor Size: Retrospective Cohort Study

We examined characteristics trends in early breast cancer patients receiving neoadjuvant chemotherapy (NAC) over a 16-year period. Our primary objective was to analyze variations in tumor stage and subtype over time. Secondary objectives included analyses of type of surgery and pathological response...

Descripción completa

Detalles Bibliográficos
Autores principales:	Houvenaeghel, Gilles, de Nonneville, Alexandre, Cohen, Monique, Viret, Frédéric, Rua, Sandrine, Sabiani, Laura, Buttarelli, Max, Charaffe, Emmanuelle, Monneur, Audrey, Jalaguier-Coudray, Aurélie, Bannier, Marie, Sabatier, Renaud, Gonçalves, Anthony
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9879000/ https://www.ncbi.nlm.nih.gov/pubmed/36714356 http://dx.doi.org/10.26502/jsr.10020251

Ejemplares similares

Mastectomy and Immediate Breast Reconstruction with Pre-Pectoral or Sub-Pectoral Implant: Assessing Clinical Practice, Post-Surgical Outcomes, Patient’s Satisfaction and Cost
por: Houvenaeghel, Gilles, et al.
Publicado: (2022)

Posterior pelvic exenteration for ovarian cancer: surgical and oncological outcomes
por: Houvenaeghel, Gilles, et al.
Publicado: (2022)

Robotic Versus Conventional Nipple-Sparing Mastectomy With Immediate Breast Reconstruction
por: Houvenaeghel, Gilles, et al.
Publicado: (2021)

Mastectomy with immediate breast reconstruction: Results of a mono-centric 4-years cohort
por: Quilichini, Olivia, et al.
Publicado: (2020)

Positive or close margins: reoperation rate and second conservative resection or total mastectomy?
por: Houvenaeghel, Gilles, et al.
Publicado: (2019)

Breast Metastasis of a Squamous Cell Carcinoma of the Uterine Cervix Mimicking Inflammatory Breast Cancer
por: Sabatier, Renaud, et al.
Publicado: (2012)

Skin sparing mastectomy and robotic latissimus dorsi-flap reconstruction through a single incision
por: Houvenaeghel, Gilles, et al.
Publicado: (2019)

Breast cancer robotic nipple sparing mastectomy: evaluation of several surgical procedures and learning curve
por: Houvenaeghel, G., et al.
Publicado: (2019)

A machine learning-based algorithm to eliminate breast and axillary surgery in patients with breast cancer and pathological complete response after neoadjuvant chemotherapy
por: de Nonneville, Alexandre, et al.
Publicado: (2023)

Lymphovascular invasion has a significant prognostic impact in patients with early breast cancer, results from a large, national, multicenter, retrospective cohort study
por: Houvenaeghel, G., et al.
Publicado: (2021)

Stem Cells Inhibition by Bevacizumab in Combination with Neoadjuvant Chemotherapy for Breast Cancer
por: Sabatier, Renaud, et al.
Publicado: (2019)

Choosing the most appropriate minimally invasive approach to treat gynecologic cancers in the context of an enhanced recovery program: Insights from a comprehensive cancer center
por: Netter, Antoine, et al.
Publicado: (2020)

Eribulin Efficacy on Brain Metastases in Heavily Pretreated Patients with Metastatic Breast Cancer
por: Sabatier, Renaud, et al.
Publicado: (2021)

Early clinical outcomes of hybrid brachytherapy for locally advanced cervical cancer: making adverse situations in a favorable scenario
por: Cagetti, Leonel Varela, et al.
Publicado: (2022)

Safety Results and Analysis of Eribulin Efficacy according to Previous Microtubules-Inhibitors Sensitivity in the French Prospective Expanded Access Program for Heavily Pre-treated Metastatic Breast Cancer
por: Sabatier, Renaud, et al.
Publicado: (2018)

Care as Usual: An Acceptable Strategy to Apply During the COVID-19 Pandemic in a French Tertiary Gynecologic Oncology Department
por: Blache, Guillaume, et al.
Publicado: (2021)

“Stealth” tumors: Breast cancer cells shun NK-cells anti-tumor immunity
por: Mamessier, Emilie, et al.
Publicado: (2012)

Early breast cancer in women aged 35 years or younger: A large national multicenter French population-based case control-matched analysis
por: Dufour, Ondine, et al.
Publicado: (2023)

Comparative genomic analysis of primary tumors and metastases in breast cancer
por: Bertucci, François, et al.
Publicado: (2016)

30 Years of Experience in the Management of Stage III and IV Epithelial Ovarian Cancer: Impact of Surgical Strategies on Survival
por: Delga, Berenice, et al.
Publicado: (2020)

Similar response profile to neoadjuvant chemotherapy, but different survival, in inflammatory versus locally advanced breast cancers
por: Monneur, Audrey, et al.
Publicado: (2017)

Enhanced Recovery after Surgery and Endometrial Cancers: Results from an Initial Experience Focused on Elderly Patients
por: Miguet, Céline, et al.
Publicado: (2023)

The need to tailor the omission of axillary lymph node dissection to patients with good prognosis and sentinel node micro‐metastases
por: Houvenaeghel, Gilles, et al.
Publicado: (2022)

Outpatient Cancer Care Delivery in the Context of E-Oncology: A French Perspective on “Cancer outside the Hospital Walls”
por: Bertucci, François, et al.
Publicado: (2019)

Transperitoneal para-aortic lymphadenectomy by robot assisted laparoscopy in 10 steps
por: Heinemann, Mellie, et al.
Publicado: (2019)

Types of Mastectomies and Immediate Reconstructions for Ipsilateral Breast Local Recurrences
por: Simon, Pauline, et al.
Publicado: (2020)

Targeting BRCA Deficiency in Breast Cancer: What are the Clinical Evidences and the Next Perspectives?
por: Nicolas, Emanuel, et al.
Publicado: (2018)

Circulating Tumor Cells and Bevacizumab Pharmacokinetics during Neoadjuvant Treatment Combining Chemotherapy and Bevacizumab for Early Breast Cancer: Ancillary Analysis of the AVASTEM Trial
por: Sabatier, Renaud, et al.
Publicado: (2021)

Associations between clinical characteristics and tumor response to neoadjuvant chemoradiotherapy in rectal cancer
por: Pang, Xiaolin, et al.
Publicado: (2021)

Down-Regulation of ECRG4, a Candidate Tumor Suppressor Gene, in Human Breast Cancer
por: Sabatier, Renaud, et al.
Publicado: (2011)

Claudin-low breast cancers: clinical, pathological, molecular and prognostic characterization
por: Sabatier, Renaud, et al.
Publicado: (2014)

New Therapeutics in HER2-Positive Advanced Breast Cancer: Towards a Change in Clinical Practices?
por: Mezni, Essia, et al.
Publicado: (2020)

The MonarchE trial: improving the clinical outcome in HR(+)/HER2(−) early breast cancer: recent results and next steps
por: Bertucci, François, et al.
Publicado: (2023)

Predictive power of tertiary lymphoid structure signature for neoadjuvant chemotherapy response and immunotherapy benefit in HER2‐negative breast cancer
por: Bertucci, François, et al.
Publicado: (2023)

Determinants of favorable or unfavorable opinion about euthanasia in a sample of French cancer patients receiving palliative care
por: de Nonneville, Alexandre, et al.
Publicado: (2018)

Prospective high-throughput genome profiling of advanced cancers: results of the PERMED-01 clinical trial
por: Bertucci, François, et al.
Publicado: (2021)

Dramatic and Delayed Response to Doxorubicin-Dacarbazine Chemotherapy of a Giant Desmoid Tumor: Case Report and Literature Review
por: Monneur, Audrey, et al.
Publicado: (2013)

CSPG4 Expression in GIST Is Associated with Better Prognosis and Strong Cytotoxic Immune Response
por: de Nonneville, Alexandre, et al.
Publicado: (2022)

Life cycle assessment data of French organic agricultural products
por: Nitschelm, Laure, et al.
Publicado: (2021)

Multiple direct and indirect mechanisms drive estrogen-induced tumor growth in high grade serous ovarian cancers
por: Ciucci, Alessandra, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_5v9r3uibk2sc3v7mbg0cg3d7i8